Tango Therapeutics (TNGX) Competitors

Ouster (NYSE:OUST) and Tango Therapeutics (NASDAQ:TNGX) are both small-cap computer and technology companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, earnings, risk, media sentiment, institutional ownership, profitability, community ranking, analyst recommendations and valuation.

Do institutionals and insiders believe in OUST or TNGX?

31.5% of Ouster shares are owned by institutional investors. Comparatively, 79.0% of Tango Therapeutics shares are owned by institutional investors. 7.8% of Ouster shares are owned by company insiders. Comparatively, 6.3% of Tango Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Is OUST or TNGX more profitable?

Ouster has a net margin of -106.50% compared to Tango Therapeutics' net margin of -284.42%. Tango Therapeutics' return on equity of -49.64% beat Ouster's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ouster	-106.50%	-65.17%	-37.02%
Tango Therapeutics	-284.42%	-49.64%	-32.00%

Which has better valuation and earnings, OUST or TNGX?

Tango Therapeutics has lower revenue, but higher earnings than Ouster. Tango Therapeutics is trading at a lower price-to-earnings ratio than Ouster, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ouster	$83.28M	5.31	-$374.11M	-$2.57	-3.46
Tango Therapeutics	$43.38M	10.10	-$101.74M	-$1.18	-3.46

Which has more risk & volatility, OUST or TNGX?

Ouster has a beta of 2.34, suggesting that its share price is 134% more volatile than the S&P 500. Comparatively, Tango Therapeutics has a beta of 0.88, suggesting that its share price is 12% less volatile than the S&P 500.

Does the media prefer OUST or TNGX?

In the previous week, Ouster had 12 more articles in the media than Tango Therapeutics. MarketBeat recorded 23 mentions for Ouster and 11 mentions for Tango Therapeutics. Tango Therapeutics' average media sentiment score of 0.74 beat Ouster's score of 0.16 indicating that Tango Therapeutics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Ouster	3 Very Positive mention(s)	2 Positive mention(s)	8 Neutral mention(s)	5 Negative mention(s)	2 Very Negative mention(s)	Neutral
Tango Therapeutics	4 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Does the MarketBeat Community favor OUST or TNGX?

Ouster received 4 more outperform votes than Tango Therapeutics when rated by MarketBeat users. However, 72.97% of users gave Tango Therapeutics an outperform vote while only 56.36% of users gave Ouster an outperform vote.

Company	Underperform	Outperform
Ouster	Outperform Votes 31 56.36%	Underperform Votes 24 43.64%
Tango Therapeutics	Outperform Votes 27 72.97%	Underperform Votes 10 27.03%

Do analysts prefer OUST or TNGX?

Ouster presently has a consensus price target of $13.00, suggesting a potential upside of 46.31%. Tango Therapeutics has a consensus price target of $13.14, suggesting a potential upside of 222.13%. Given Tango Therapeutics' stronger consensus rating and higher probable upside, analysts clearly believe Tango Therapeutics is more favorable than Ouster.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ouster	0 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.80
Tango Therapeutics	0 Sell rating(s)	0 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	3.00

Summary

Tango Therapeutics beats Ouster on 11 of the 18 factors compared between the two stocks.